Murine bone marrow cells were fractionated by fluorescence-activated cell sorting into Rh123" Lin-c-kit' Ly6A+, Rh123h' Lin-c-kiP Ly6A'. and Lin-c-kit' Ly6A-populations within which most, if not all, of the hematopoetic activities of the marrow resided. The Rh123" Lin-c-kit' Ly6A' cells, which consist exclusively of small-or medium-sized lymphocyte-like cells, are highly enriched for long-term hematopoietic in vivo repopulating cells. The enrichment factor for these cells from the marrow was estimated as 2,000-fold. The Rh123h' Lin-c-kit" Ly6A' cells, although also highly enriched for day-l2 spleen colony-forming units, were relatively depleted of long-term in vivo repopulation capacity.
Recent advances in fluorescence-activated cell sorting (FACS) technology have succeeded in producing enriched populations of hematopoietic stem cells and have allowed some definition of the surface phenotype of these cells. These cells have been shown to express low levels of Thy-l,'*." CD4,I4 heat-stable antigen,I3 high levels of c-kit receptor,""' gens,",22 and binding sites for the wheat-germ aggl~tinin.*'~*~ Using this cell separation technique, day 12 CFU-S, cells conferring radioprotection, and LTRCs have usually been copurified. However, Jones et a12' showed that the LTRCs can be separated by counterllow centrifugal elutriation (CCE), from day-8 and day-l2 CFU-S, cells conferring radioprotection, and the putative short-term hematopoietic in vivo repopulating cells.
We have previously shown that rhodamine 123 can be used to subfractionate the Lin-Ly6A+ stem cell population into two cell populations, Rh123'" and Rl1123~'. Although both populations confer similar levels of radioprotection to recipients and have similar surface phenotypes and content of day-l2 CFU-S, most if not all LTRCs are only found in the Rh123'" fraction. " We report here that, with the use of anti-c-kit receptor monoclonal antibody (MoAb), the population can be further fractionated into kit' and kit-populations. All the hematopoietic activities observed with the Rh123'"Lin-Ly6A' population (day-l2 CFU-S, radioprotection, and LTRC) have been further copurified within the ckit' fraction. Studies on both Rh123hi Lin-c-kit+ Ly6A' and Lin-c-kit' Ly6A-populations indicate that these populations have in vivo repopulation kinetics characteristic of the putative short-term hematopoietic repopulating cells. Furthermore, the Lin-c-kit+ Ly6A-population can be characterized as committed progenitors because they are stimulated to form colonies and clusters in semi-solid culture medium in the presence of single cytokine(s) and minimal synergistic interactions between growth factors are observed.
Ly6A/E (~c a~~) , 1 2 . 1 3 . . ' 6 .~9 , 2 0 . 2 4 class-I histocompatibility anti-
MATERIALS AND METHODS

Animals.
Mice were used at 6 to 12 weeks of age and were of the following strains: C57BUKa-Thy-1.1 (Thy-1.1. Ly5.2) and C57B L/ 6-Ly-5.1-PepSb (Thy-1.2, Ly5.1). They were bred at the Walter and Eliza Hall Institute of Medical Research animal facility under specific pathogen-free conditions and were maintained on acidified water. For personal use only. on August 16, 2017 . by guest www.bloodjournal.org From FACS. To prepare cells for FACS, 10 C57BLKa-Thy-1.1 mice (Ly5.2) were killed by cervical dislocation, and the cells from both femurs and tibiae were flushed out using a 2.5-mL syringe with a 21-guage needle. After washing, the bone marrow cells were resuspended in 10 mL of balanced salt solution containing 5% fetal calf serum (BSS.FCS) and 0.1 pg/mL rhodamine 123 (Eastman Kodak CO, Rochester, NY) and incubated at 37°C for 30 minutes. After washing once, the cells were resuspended in 10 mL of fresh BSS.FCS, and incubated at 37°C for another 30 minutes. The cell suspension was then diluted further by the addition of 10 mL of BSS.FCS, layered on top of Ficoll (Pharmacia Inc, Piscataway, NJ), and centrifuged at 1,600g for 10 minutes at room temperature. Lightdensity viable bone marrow cells were recovered and washed with 10 mL of BSS.FCS. After washing and resuspension in 3 mL of BSS.FCS, the cells were incubated on ice for 15 minutes with a mixture of rat MoAbs, GK-1.5, 53-6.72, 53-7.3.13, RA3-6B2, MI/ 70.15.1 1.5, and RB6-8C5, reactive with specific antigens on mature T, B, and myeloid cells (neutrophils and monocytes/macrophages). After washing with 10 mL of BSS.FCS and centrifugation through an FCS underlayer, the cells were resuspended in 1 mL of BSS.FCS, mixed together with 1 mL of prewashed magnetic Dynalbeads (Dynalbeads M450; Dyna Inc, Oslo, Norway), and incubated for 20 minutes at 4°C with constant mixing. After diluting the mixture by adding 5 mL of fresh BSS.FCS, the beads, together with the cells bound to them, were removed magnetically. The procedure was repeated twice to both bead and bead-free cell populations. The bead-free cell fractions were pooled, centrifuged, and then stained sequentially for 15 minutes each in 0.5 mL volume on ice with phycoerythrin (PE)-conjugated goat antirat Ig (mouse Ig absorbed), a mixture of allophycocyanin (APC)-conjugated E13-161.7 and biotinylated ACK-2 (the ACK-2 MoAb was kindly provided by Dr S.I. Nishikawa, Kumamoto University, Kumamoto, Japan) MoAbs, and then Texas Red-avidin. Each staining step was followed by a washing step with 10 mL of BSS.FCS, and the bone marrow cells were preincubated with 50 pg of normal rat Ig for 2 to 3 minutes before the addition of the mixture of APC-E13-161.7 and biotinylated ACK-2 MoAbs. After the final wash, the cells were resuspended in 3 mL of BSS.FCS containing 10 pg/mL of propidium iodide (Calbiochem
Corp. La Jolla, CA) and filtered through a 63-pm pore size nylon screen. FACS was performed using an unmodified FACStar-Plus instrument (Becton Dickinson Immunocytometry Systems, San Jose, CA). All cells were kept at 4°C throughout the whole procedure. After completion of cell sorting, the deflected cells were centrifuged at 1,500 rpm for 5 minutes, resuspended, and counted using a hematocytometer. In vitro cultures. For semi-solid agar cultures, 100 cells from indicated individual fractions were cultured in duplicate 35-mm petri dishes. The cells were cultured in 1 mL of semi-solid agar medium and stimulated by individual or indicated combinations of the following stimuli at 1, OOO U/mL, unless specified otherwise: purified recombinant murine interleukin-3 (E-31, granulocyte-macrophage colony-stimulating factor (GM-CSF), macrophage colony-stimulating factor (M-CSF), or human granulocyte colony-stimulating factor (G-CSF), prepared and kindly provided by Dr N.A. Nicola (Hall Institute, Melbourne, Australia). Recombinant murine L 6 (kindly provided by Dr R. Simpsom, JPLC, Hall Institute), rat stem cell factor (SCF; kindly provided by Dr K. Zsebo, Amgen, Thousand Oaks, CA), and human IL-I (kindly provided by Dr A. Gearing, Oxford University, Oxford, UK) were used at 5 ng/mL, 100 ng/mL, and 1 UlmL, respectively. Cells were cultured in Dulbecco's modified medium supplemented with 20% FCS and incubated at 37°C with 10% CO, in a fully humidified atmosphere. Cultures of Lin-c-kit' Ly6A-and Lin-c-kit-Ly6A-cells were scored at day 7 of incubation for both colonies (>50 cells) and clusters (3 to 50 cells). For cultures of Rh123'O Lin-c-kif' Ly6A+, Rh123'" Lin-c-kit-Ly6A+, and Rh123"' Lin-c-kit' Ly6A' cells, colonies (>50 cells) were scored at day 12 of incubation.
Transplantation. Recipient animals (C57BU6-Ly-5.1-Pep3b Ly5.1) were exposed to 11.0 Cy of radiation from a '37Cs source (Atomic Energy, Ottawa, Canada) at a dose rate of 3 1 cGy/min. The 11 .O-Cy dose was delivered in two equal exposures administered 3 hours apart. Irradiated recipients received transplants intravenously with the indicated numbers of cells from individual fractions. Animals were maintained on aqueous antibiotics (neomycin sulphate at 
Unstained marrow cells are shown as a dashed line in (e).
For personal use only. on August 16, 2017 . by guest www.bloodjournal.org From Table 1 
RESULTS
Fractionation of marrow cells by expression c-kit receptors and Ly6A antigens. Figure 1 shows the flow cytometric analysis of normal bone marrow cells after sequential incubation with rhodamine 123, a combination of lymphoid and myelo-monocytic lineage-specifc MoAbs (GK-I S , 53-6.72, 53-7.3.13, RA3-6B2. Mli70, and RB6-8C5), and then a mixture of anti-c-kit receptor and anti-Ly6A MoAbs as described in Materials and Methods. About 6% to 8% and 8% to 10% of the marrow cells were c-kit' and Ly6A', respectively ( Fig 1A) . The staining of c-kit receptor and Ly6A antigen in the marrow cell population was mostly mutually exclusive in that majority of the c-kit' cells were Ly6A-and vice versa. Figure IB (panel h) marrow cell populations. Most, if not all, of the Lin-c-kit' Ly6A-cells were brightly stained with rhodamine 123 (ie, Rh123hi). This population constituted 4% to 7% of the total marrow population and was used as a reference population to define the sort gate on the rhodamine 123 fluorescence parameter and to subdivide the Lin-c-kit' Ly6A' population into Rh 123'" and Rh 1 23h' fractions. The resulting sort gate on rhodamine 123 using this criterion was similar to that we have set in previous studies.'" Table 1 summarizes the cellular content, based on microscopic examination, of individual fractions isolated by FACS using parameters as described above. The Rh123'" Lin-ckit' Ly6A' fraction constituted 0.1% to 0.2% of total marrow population and was composed exclusively of small-to medium-sized lymphocyte-like cells (Fig 2A) . About 80% of the Rh123hi Lin-c-kit' Ly6A' population was lymphocyte-like cells, with the remaining 20% of the population being blasts. Undifferentiated blast cells, some with prominent cytoplasmic granules, are the predominant cell type found in the Lin-c-kit' Ly6A-(Rh123h') population ( Fig  2B) . The Lin-c-kit-Ly6A-population was composed of heterogenous cell types, including lymphocyte-like cells, blasts, monocytes, erythroblasts, and eosinophils. For personal use only. on August 16, 2017 . by guest www.bloodjournal.org From In vitro analysis. To evaluate the clonogenic cell content of individual fractions, 100 sorted cells of individual fractions were plated in semi-solid agar medium stimulated with various cytokines as indicated. The results are summarized in Table 2 . No colony formation was seen in cultures of Lin-c-kit-Ly6A-or Rh123'" Lin-c-kit-Ly6A' cells when they were stimulated with either single cytokine(s), combinations of cytokines, or a mixture of seven cytokines (Multi-F; containing a combination of SCF, IL-l, IL-3, IL-6, G-CSF, GM-CSF, and M-CSF). This mixture of cytokines has previously been shown to be optimal for stimulating colony formation by Rh1 23'" L& Ly6A' cells." In agreement with previous studies on the Rh123'" Lin-Ly6A' population, the Rh123'" Lin-c-kit+ Ly6A' cells did not proliferate in the presence of single cytokine(s) ( Table 2 ). However, macroscopic colonies, reaching a colony size greater than 0.5 mm in diameter by day 12 of incubation, developed when SCF plus IL-3, SCF plus IL-6, or SCF plus G-CSF were present in the cultures. However, no colony formation was seen in cultures when they were stimulated with combinations of SCF with GM-CSF or SCF with M-CSF. Similar in vitro growth behavior was observed with Rh123h' Lin-c-kit+ Ly6A' cells, except that 10% to 15% of these cells could form colonies in response in the presence of either IL-3 alone or a combination of SCF and GM-CSF. High plating efficiency of Rh123'" Lin-c-kit+ Ly6A' (80% 2 23%, mean t SD) and Rh123h' Lin-c-kit+ Ly6Af cells (67% t 15%) were observed when they were stimulated with Multi-F. In some experiments, close to 100% plating efficiency was observed with the Rh123'" Lin-c-kif+ Ly6A' population. In contrast to the Lin-c-kit+ Ly6A+ populations, the Lin-ckit+ Ly6A-cells formed colonies and clusters after 7 days of incubation when stimulated with single cytokine(s Rl1123~', Lin-, c-kit', Ly6A-cells. No marked synergistic interactions between SCF and another cytokine(s) in colony and cluster formation was observed using these latter cells.
CFU-S content. We next evaluated the CFU-s content of individual fractions by injecting different numbers of sorted cells into lethally irradiated recipients. The recipients were killed and examined for macroscopic spleen nodules at day 8 or 12 after transplantation. The results are summarized in Table 3 . Both Rh123'" Lin-c-kit' Ly6A' and Rh123h' Lin-c-kit' Ly6A' populations contained no detectable day-8 CFU-s but had a similar day-l2 CFU-s content. Means of 6.9 2 2.3 and 6.5 ? 2.2 day-l2 spleen colonies were observed when 100 Rh123'" Lin-c-kit' Ly6A+ and Rl-1123~' Lin-c-kit' Ly6A+ cells were transplanted, respectively. Transplantation of 500 Lin-c-kit+ Ly6A-cells led to the formation of 1.9 ? 2.0 and 3.2 2 2.5 spleen colonies, respectively, on day 8 and day 12 after transplantation. Few day-8 or day-l2 CFU-S could be detected in mice injected either with Lin-c-kit-Ly6A' or with Lin-c-kit-Ly6A-cells.
Rh123'' Lin-c-kit' Ly6A' cell population is enriched for long-term in vivo hematopoietic repopulating cells. We have previously shown that the marrow Rh123'" Lin-Ly6A+ population is highly enriched for long-term in vivo hematopoietic repopulating cells. About 30% to 50% of the Rh123'" Lin-Ly6A+ population were c-kit+ (data not shown). In the above experiments, we showed that all the day-l2 CFU-S and in vitro clonogenic cells resided within the c-kit' fraction of the Rh123'" Lin-Ly6A+ population. We next investigated whether the cells responsible for long-term in vivo hematopoietic repopulating activity in the Rh123'" Lin-Ly6A+ fraction were c-kit+ or not. To examine this, graded numbers of both Rh123'" Lin-c-kit' Ly6A' and Rh123'" Lin-c-kitLy6A' cells, prepared from C57BL16 ,Ly-5.2 marrow, were transplanted into lethally irradiated congenic Ly-5.1 recipients with or without Ly-5.1 CBM cells. Surviving transplanted recipients were then sequentially sampled from 5 to 44 weeks posttransplantation. The results of these experiments are shown in Table 4 . The Rh123'" Lin-c-kit-Ly6A' population conferred minimal radioprotection to the lethally irradiated recipients. Furthermore, no donor-derived cells could be detected in the surviving recipients during an observation period up to 1 year (Table 4 ) or on retransplantation of the primary recipients' marrow cells into secondary lethally irradiated recipients (data not shown). In contrast, the Rh123'" Lin-c-kit' Ly6A+ cells were capable of conferring efficient radioprotection on lethally irradiated recipients.
Transplantation of as few as 10 Rhl23'" Lin-c-kit' Ly6A+ cells alone resulted in about 50% survival of the recipients from the lethal effects of the total body irradiation. Cell dose-dependent donor cell engraftment was observed in the circulating blood cell population of these surviving recipients. Transplantation of 10, 33, and 100 Rh123'" Lin-c-kit' Ly6A' cells, in the absence of any filler cells, resulted in 21% 2 25%, 43% i-20%, and 56% ? 12%; 26% t 18%, 59% 2 20%, and 77% ? 14%; and 20% i 26%, 53% t 32%, and 73% t 24% donor cell engraftment in the peripheral blood measured at 5, 10 to 13, and 43 to 44 weeks posttransplantation, respectively. These data strongly suggest that the Rh123'" Lin-c-kit' Ly6A+ fraction possessed most, if not all, of the in vivo hematopoietic repopulation activity of the Rh123'" Lin-Ly6A+ population. Cotransplantation of CBM led to a better survival of recipients, particularly those receiving low numbers of transplanted cells. Lower levels of donor cell engraftment were usually observed when these recipients were compared with those that underwent transplantation without any filler cells. However, the difference was significant only in the early phase of hematopoietic recovery such that, at 5 weeks posttransplantation, a mean of 7% t 6% and 14% t 4% versus 21% t 25% and 43% t 20% donor cells were observed in recipients receiving IO and 33 sorted Rh123'" Lin-c-kit' Ly6A' cells with and without CBM cells, respectively ( P < .05). The difference became minimal by 43 to 44 weeks. Figure 3 shows the effect of variation in cell dose on the level of hematopoietic reconstitution when using FACSpurified Rh123'" Lin-c-kit+ Ly6A' or unfractionated normal bone marrow cells. The level of donor cell engrafment in the cirulating peripheral blood nucleated cell population was determined in individual recipients after a minimium period of 10 months posttransplantation. It can be estimated from the graph that the enrichment factor for the Rh123'" Lin-ckit' Ly6A' cells obtained from normal bone marrow was about 2,000-fold.
Heterogeneity within the Rh123" Lin-c-kit' Ly6A+ population. Sequential sampling of individual recipients showed a similar pattern of engraftment pattern to that we have previously described using the Thy-l'" Lin-Ly6A' cells.'? However, it required only 100 Rh123'" Lin-c-kit' Ly6A' cells to produce an engraftment pattern similar to that generated by 400 to 560 Thy-l'" Lin-Ly6A' cells (data not shown). A more heterogenous pattern of engraftment was seen when lower numbers of cells were transplanted. Figure  4 shows the three major engraftment patterns seen in 19 recipients transplanted with 10 Rh123" Lin-c-kit' Ly6A' For cells (1 3 of whom were cotransplanted with CBM cells). All recipients showed detectable levels of donor cells (range, 1% to 24%) by week 5 posttransplantation. Five recipients died between 13 and 25 weeks posttransplantation. The majority of the recipients showed either a low (<20%) and declining level of engraftment (Fig 4A) throughout the observation period or a peak level of donor cell engraftment between 10 and 22 weeks posttransplantation, after which the level subsequently declined (Fig 4B) . Figure 4C shows a sustained and high (>50%) level of engraftment seen in three recipients, whereas one showed a relatively delayed onset (at least 8 weeks posttransplantation) of engraftment. Another recipient showed a relatively low level of donor cell engraftment for the first 22 weeks, with a slow but steady increase in donor cell level afterward. Receipients with or without CBM cells distributed evenly within the three engraftment patterns. It is presumed that the donor cell engraftment pattern displayed in Fig 4C is the result of en-1411 graftment of LTRCs. Secondary transplantation experiments of these recipients were performed. A high level of donor cell engraftment was seen only in recipients transplanted with marrow cells from the primary recipients shown in Fig  4C but not from those shown in Fig 4A and B (data not shown).
Rh123h' Lin-c-kit' Ly6A' and Lin-c-kit' Ly6A-cells are short-term in vivo repopulating cells. In contrast to the Rh123'"Lin-c-kit' Ly6A+ population, few donor cells were detected in recipients 6 to 10 months after transplantation with 100 to 500 Rh123h' Lin-c-kit' Ly6A+ or 2 to IO X IO' Lin-c-kit' Ly6A-cells (data not shown). We next investigated whether these two cell populations can contribute to early hematopoietic recovery after lethal irradiation. To compare donor cell engraftment in peripheral blood during the early phase of hematopoietic recovery, lethally irradiated recipients were transplanted intravenously with 100 Rh123'" Lin-c-kit' Ly6A+, 500 Rh123h' Lin-c-kit' Ly6A', lo4 Lin-c-kit+ Ly6A-, and 2 X 10' unfractionated bone marrow cells. One hundred Rh123'" Lin-c-kit' Ly6A+ and 2 X lo5 bone marrow cells were chosen because the enrichment factor for long-term in vivo hematopoietic repopulating cells from the marrow was estimated to be approximately 2,000-fold (Fig 3) . Ten thousand Lin-c-kit+ Ly6A-cells were chosen because no recipients of lo3 Lin-c-kit' Ly6A-cells survived 3 weeks after transplantation (data not shown). A minimum of four recipients from each group were killed at early weekly time points to provide enough cells for flow cytometry analysis. The remaining recipients from each cell group surviving more than 10 weeks posttransplantation were bled sequentially at the indicated time points. Donor cell engraftment was determined by flow cytometry as described in Materials and Methods and the results are shown in Fig 5. Apart from a relatively lower level of engraftment in the first 3 weeks posttransplantation, recipients of 100 Rh123'" Lin-c-kit' Ly6A' cells displayed almost identical engraftment kinetics to those of normal bone marrow cell group. In contrast, recipients of 500 Rh123h' Lin-c-kir+ Ly6A+ and IO4 Lin-c-kit+ Ly6A-cells showed a peak level of donor cell engraftment with in the first 2 to 3 weeks after transplantation that subsequently declined.
DISCUSSION
The present studies confirmed earlier studies that c-kit receptors are expressed on most, if not all, primitive hematopoietic stem and committed progenitor cells.''"8 In the present studies, we further showed that the Rh123'" Lin-c-kit' Ly6A+ cell population is highly enriched for long-term in vivo hematopoietic repopulating cells, whereas Rh1 23h' Linc-kit' Ly6A' and Rh123h' Lin-c-kir' Ly6A ~ cells could be characterized as short-term hematopoietic repopulating cells by their in vivo repopulation behavior (Fig 5) . Although both Rh123h' Lin-c-kit' Ly6A' and Rh123h' Lin-c-kit' Ly6A-cell populations can be characterized as short-term repopulating cells, the former population is considered to be a relatively more immature population because they do not have day-8 CFU-S activity and do not proliferate in vitro in the presence of single cytokines, except IL-3 ( lation contained a similar frequency of day-8 and day-l2 CFU-S and was also highly enriched for hematopoietic progenitor cells that grew in the presence of single cytokines and showed minimal synergism between cytokines. We further show here that most, if not all, Lin-c-kit' Ly6A-cells are undifferenitated blasts and Rh123h'. These observations indicate that the loss of Ly6A antigen expression is accompanied with differentiation of hematopoietic stem cells to progenitor cells.
The existence of short-and long-term in vivo hematopoietic repopulating cells has now been widely recognized. However, the identity of these cells has not been well defined. Day-8 CFU-s, day-l2 CFU-s, and cells conferring radioprotection have frequently been referred to cells responsible for short-term repopulating activity. It has been shown that the LTRCs are small lymphocyte^^^ or blasts with low Hoechst 33342 and rhodamine 123 f l u o r e s~e n c e .~~~~~
In this report, we show that Rh123" Lin-c-kit+ Ly6A+ cells, composed of small-to medium-size lymphocyte-like cells, are highly enriched for long-term repopulating cells, whereas IU1123~' Lin-c-kit+ Ly6A' and Rh123h' Lin-c-kit+ Ly6A-cells are only capable of transient hematopoietic repopulation, mostly within the first 2 to 3 weeks posttransplantation.
In the present study, day-l2 Cm-S, cells conferring radio-LI AND JOHNSON protection to lethally irradiated recipients, and long-term hematopoietic engraftment copurified. This finding is in contrast to the reported results of Jones et a1" that long-term repopulating cells (measured at 6 months posttransplantation) can be separated from CFU-s by counterflow centrifugal elutriation. However, subsequent studies by Orlic and Bodine" showed that only a subpopulation of LTRCs was able to be separated from CFU-s and the bulk of them actually copurified. Further purification studies showed that the Lin c-kit hr cells in both FR25 and FR30 were highly enriched for LTRCs.Ih
More than I % donor cell engraftment 4 to 6 months after transplantation is commonly used as a readout for LTRC.22 By this criterion, the Rh123'" Lin c-kir' Ly6A' cells are highly enriched for LTRCs ( I in 5 cells) as all ( I 9/19) and 88% (IS/17) recipients receiving 10 such cells showed greater than 1% donor cells in peripheral blood at S and 22
to 26 weeks posttransplantation, respectively. However, they are still a heterogeneous population, as shown by the engraftment patterns seen in these recipients (Fig 4) . Only 4 of 14 recipients survived by 43 to 48 weeks posttransplantation showed a high level of donor cell engraftment. The secondary transplantation experiments with these primary recipients indicated that the subsequent decline in donor cell engraftment is most likely due to the exhaustion of repopulating capacity of the transplanted stem cells. If one takes this as a more stringent criterion for LTRCs, then the frequency of LTRCs within the Rh123'" Lin-c-kit' Ly6A' population is estimated to be only 2 to 3 per 100 cells.
